Literature DB >> 943037

The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.

R Jenssen, H L Jenssen, H Köhler, H Friemel.   

Abstract

The MEM test by FIELD and CASPARY has been investigated for its importance in analyzing the cell-mediated immunity in ophthalmology. Sensitized lymphocytes of patients are incubated in vitro either with basic encephalitogenic protein for investigating malignoma or with various eye antigens for investigating chronic ocular diseases. The eye antigens have been fractionated by gel chromatography and identified by various immune sera. The sensitized lymphocytes are released in vitro by incubation with antigen a factor which reduces the electrophoretic mobility of guinea pig macrophages.

Entities:  

Mesh:

Year:  1976        PMID: 943037

Source DB:  PubMed          Journal:  Mod Probl Ophthalmol        ISSN: 0077-0078


  5 in total

1.  Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.

Authors:  H L Jenssen; H Köhler; J Günther; B Klausch; W Straube; R Hofmann; H H Büttner
Journal:  Arch Gynakol       Date:  1976-03-05

2.  [Autoimmunity in chronic inflammatory eye disease (author's transl)].

Authors:  R Jenssen; H L Jenssen; H Werner; H Köhler
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1976-12-31

3.  A contribution to immunological tumour diagnostics in urology.

Authors:  M Günther; A Friedrich; T Erdmann; H L Jenssen; H Werner; M Seyfarth; H Köhler
Journal:  Int Urol Nephrol       Date:  1978       Impact factor: 2.370

4.  Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours.

Authors:  A H Rahi; G Otiko; A F Winder
Journal:  Br J Ophthalmol       Date:  1976-08       Impact factor: 4.638

5.  Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.

Authors:  W Hoffmann; W Werner; R Steiner; R Kaufmann
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.